Home › Funds › Clayton, Dubilier & Rice, LLC › AGL
Clayton, Dubilier & Rice, LLC position in AGL
AGILON HEALTH INC · Health Care
Clayton, Dubilier & Rice, LLC reported holding 4,000,000 shares of AGL (AGILON HEALTH INC) in its Q3 2026 13F filing — a position valued at US$318.4M, representing 43.91% of its reported portfolio and ranking #1 among its reported holdings. Clayton, Dubilier & Rice, LLC has disclosed AGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Clayton, Dubilier & Rice, LLC's AGL position evolved
Clayton, Dubilier & Rice, LLC first disclosed a stake in AGL in Q3 2023 at 100,000,000 shares (US$1.78B). Across 13 filings, Clayton, Dubilier & Rice, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 4,000,000 shares valued at US$318.4M. Notable position changes include a 96% trim in Q1 2026 (shares rose 1255% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 100.00M | $1.78B | New |
| Q4 2023 | 100.00M | $1.25B | Hold |
| Q1 2024 | 100.00M | $610.00M | Hold |
| Q2 2024 | 100.00M | $654.00M | Hold |
| Q3 2024 | 100.00M | $393.00M | Hold |
| Q4 2024 | 100.00M | $190.00M | Hold |
| Q1 2025 | 100.00M | $433.00M | Hold |
| Q2 2025 | 100.00M | $230.00M | Hold |
| Q3 2025 | 100.00M | $103.00M | Hold |
| Q4 2025 | 100.00M | $69.00M | Hold |
| Q1 2026 | 4.00M | $31.64M | Reduce |
| Q2 2026 | 4.00M | $428.72M | Hold |
| Q3 2026 | 4.00M | $318.36M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AGL and 13F data
AGL (AGILON HEALTH INC) is a Health Care company. 33 other funds we track also report a position in AGL — the largest reported positions include North Peak Capital Management, LLC (US$126.1M), Durable Capital Partners LP (US$47.2M), Rock Springs Capital Management LP (US$28.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AGL
- North Peak Capital Management, LLC 1.58M sh · $126.14M · Q3 2026
- Durable Capital Partners LP 440.64K sh · $47.23M · Q2 2026
- Rock Springs Capital Management LP 262.60K sh · $28.15M · Q2 2026
- JOSH ARNOLD INVESTMENT CONSULTANT, LLC 73.00K sh · $7.82M · Q2 2026
More on Clayton, Dubilier & Rice, LLC
FAQ
How long has Clayton, Dubilier & Rice, LLC held AGL?
Clayton, Dubilier & Rice, LLC has disclosed AGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Clayton, Dubilier & Rice, LLC's current position in AGL?
As of Q3 2026, Clayton, Dubilier & Rice, LLC holds 4.00M shares of AGL (AGILON HEALTH INC), valued at $318.36M, representing 43.91% of its reported portfolio and ranking #1.
Has Clayton, Dubilier & Rice, LLC been buying or selling AGL?
In the latest 13F filing (Q3 2026), Clayton, Dubilier & Rice, LLC held unchanged its position in AGL.
Which other funds hold AGL?
Other major institutional holders of AGL include North Peak Capital Management, LLC, Durable Capital Partners LP, Rock Springs Capital Management LP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.